{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T15:05:42Z","timestamp":1772809542626,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The network-based proximity between drug targets and disease genes can provide novel insights regarding the repercussions, interplay, and repositioning of drugs in the context of disease. Current understanding and treatment for reversing of the fibrotic process is limited in systemic sclerosis (SSc). We have developed a network-based analysis for drug effects that takes into account the human interactome network, proximity measures between drug targets and disease-associated genes, genome-wide gene expression and disease modules that emerge through pertinent analysis. Currently used and potential drugs showed a wide variation in proximity to SSc-associated genes and distinctive proximity to the SSc-relevant pathways, depending on their class and targets. Tyrosine kinase inhibitors (TyKIs) approach disease gene through multiple pathways, including both inflammatory and fibrosing processes. The SSc disease module includes the emerging molecular targets and is in better accord with the current knowledge of the pathophysiology of the disease. In the disease-module network, the greatest perturbing activity was shown by nintedanib, followed by imatinib, dasatinib, and acetylcysteine. Suppression of the SSc-relevant pathways and alleviation of the skin fibrosis was remarkable in the inflammatory subsets of the SSc patients receiving TyKI therapy. Our results show that network-based drug-disease proximity offers a novel perspective into a drug\u2019s therapeutic effect in the SSc disease module. This could be applied to drug combinations or drug repositioning, and be helpful guiding clinical trial design and subgroup analysis.<\/jats:p>","DOI":"10.1038\/s41598-020-70280-y","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T10:03:50Z","timestamp":1596794630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Network-based modeling of drug effects on disease module in systemic sclerosis"],"prefix":"10.1038","volume":"10","author":[{"given":"Ki-Jo","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Jin","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Su","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilias","family":"Tagkopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,7]]},"reference":[{"key":"70280_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrg.2017.8","author":"S Yi","year":"2017","unstructured":"Yi, S. et al. Functional variomics and network perturbation: Connecting genotype to phenotype in cancer. Nat. Rev. Genet. https:\/\/doi.org\/10.1038\/nrg.2017.8 (2017).","journal-title":"Nat. Rev. Genet."},{"key":"70280_CR2","doi-asserted-by":"publisher","first-page":"e1001095","DOI":"10.1371\/journal.pcbi.1001095","volume":"7","author":"YA Kim","year":"2011","unstructured":"Kim, Y. A., Wuchty, S. & Przytycka, T. M. Identifying causal genes and dysregulated pathways in complex diseases. PLoS Comput. Biol. 7, e1001095. https:\/\/doi.org\/10.1371\/journal.pcbi.1001095 (2011).","journal-title":"PLoS Comput. Biol."},{"key":"70280_CR3","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nature08454","volume":"461","author":"EE Schadt","year":"2009","unstructured":"Schadt, E. E. Molecular networks as sensors and drivers of common human diseases. Nature 461, 218\u2013223. https:\/\/doi.org\/10.1038\/nature08454 (2009).","journal-title":"Nature"},{"key":"70280_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.pharmthera.2013.01.016","volume":"138","author":"P Csermely","year":"2013","unstructured":"Csermely, P., Korcsmaros, T., Kiss, H. J., London, G. & Nussinov, R. Structure and dynamics of molecular networks: A novel paradigm of drug discovery: a comprehensive review. Pharmacol. Ther. 138, 333\u2013408. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.01.016 (2013).","journal-title":"Pharmacol. Ther."},{"key":"70280_CR5","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1039\/c5mb00444f","volume":"11","author":"A Segura-Cabrera","year":"2015","unstructured":"Segura-Cabrera, A., Singh, N. & Komurov, K. An integrated network platform for contextual prioritization of drugs and pathways. Mol. Biosyst. 11, 2850\u20132859. https:\/\/doi.org\/10.1039\/c5mb00444f (2015).","journal-title":"Mol. Biosyst."},{"key":"70280_CR6","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1161\/circgenetics.113.000123","volume":"7","author":"B Zhang","year":"2014","unstructured":"Zhang, B., Tian, Y. & Zhang, Z. Network biology in medicine and beyond. Circ. Cardiovasc. Genet. 7, 536\u2013547. https:\/\/doi.org\/10.1161\/circgenetics.113.000123 (2014).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"70280_CR7","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nrg1872","volume":"7","author":"S Philippi","year":"2006","unstructured":"Philippi, S. & Kohler, J. Addressing the problems with life-science databases for traditional uses and systems biology. Nat. Rev. Genet. 7, 482\u2013488. https:\/\/doi.org\/10.1038\/nrg1872 (2006).","journal-title":"Nat. Rev. Genet."},{"key":"70280_CR8","doi-asserted-by":"publisher","first-page":"10331","DOI":"10.1038\/ncomms10331","volume":"7","author":"E Guney","year":"2016","unstructured":"Guney, E., Menche, J., Vidal, M. & Barabasi, A. L. Network-based in silico drug efficacy screening. Nat. Commun. 7, 10331. https:\/\/doi.org\/10.1038\/ncomms10331 (2016).","journal-title":"Nat. Commun."},{"key":"70280_CR9","doi-asserted-by":"publisher","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","volume":"1","author":"Y Allanore","year":"2015","unstructured":"Allanore, Y. et al. Systemic sclerosis. Nat. Rev. Dis. Primers. 1, 15002. https:\/\/doi.org\/10.1038\/nrdp.2015.2 (2015).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"70280_CR10","doi-asserted-by":"publisher","first-page":"e000260","DOI":"10.1136\/rmdopen-2016-000260","volume":"2","author":"Y Allanore","year":"2016","unstructured":"Allanore, Y., Matucci-Cerinic, M. & Distler, O. Treatment of systemic sclerosis: Is there any hope for the future?. RMD Open 2, e000260. https:\/\/doi.org\/10.1136\/rmdopen-2016-000260 (2016).","journal-title":"RMD Open"},{"key":"70280_CR11","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrrheum.2013.46","volume":"9","author":"CP Denton","year":"2013","unstructured":"Denton, C. P. & Ong, V. H. Targeted therapies for systemic sclerosis. Nat. Rev. Rheumatol. 9, 451\u2013464. https:\/\/doi.org\/10.1038\/nrrheum.2013.46 (2013).","journal-title":"Nat. Rev. Rheumatol."},{"key":"70280_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/ejhg.2013.96","volume":"22","author":"EM Ramos","year":"2014","unstructured":"Ramos, E. M. et al. Phenotype-Genotype Integrator (PheGenI): Synthesizing genome-wide association study (GWAS) data with existing genomic resources. Eur. J. Hum. Genet. 22, 144\u2013147. https:\/\/doi.org\/10.1038\/ejhg.2013.96 (2014).","journal-title":"Eur. J. Hum. Genet."},{"key":"70280_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/database\/bav028","author":"J Pinero","year":"2015","unstructured":"Pinero, J. et al. DisGeNET: A discovery platform for the dynamical exploration of human diseases and their genes. Database Oxford https:\/\/doi.org\/10.1093\/database\/bav028 (2015).","journal-title":"Database Oxford"},{"key":"70280_CR14","doi-asserted-by":"publisher","first-page":"D786","DOI":"10.1093\/nar\/gkn580","volume":"37","author":"AP Davis","year":"2009","unstructured":"Davis, A. P. et al. Comparative toxicogenomics database: A knowledgebase and discovery tool for chemical-gene-disease networks. Nucleic Acids Res. 37, D786-792. https:\/\/doi.org\/10.1093\/nar\/gkn580 (2009).","journal-title":"Nucleic Acids Res."},{"key":"70280_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W da Huang","year":"2009","unstructured":"da Huang, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357. https:\/\/doi.org\/10.1038\/nprot.2008.211 (2009).","journal-title":"Nat. Protoc."},{"key":"70280_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrrheum.2010.48","volume":"6","author":"M Ramos-Casals","year":"2010","unstructured":"Ramos-Casals, M., Fonollosa-Pla, V., Brito-Zeron, P. & Siso-Almirall, A. Targeted therapy for systemic sclerosis: How close are we?. Nat. Rev. Rheumatol. 6, 269\u2013278. https:\/\/doi.org\/10.1038\/nrrheum.2010.48 (2010).","journal-title":"Nat. Rev. Rheumatol."},{"key":"70280_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/1346-8138.13026","volume":"43","author":"K Yanaba","year":"2016","unstructured":"Yanaba, K. Strategy for treatment of fibrosis in systemic sclerosis: Present and future. J. Dermatol. 43, 46\u201355. https:\/\/doi.org\/10.1111\/1346-8138.13026 (2016).","journal-title":"J. Dermatol."},{"key":"70280_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00281-015-0551-z","volume":"38","author":"O Distler","year":"2016","unstructured":"Distler, O. & Cozzio, A. Systemic sclerosis and localized scleroderma\u2013current concepts and novel targets for therapy. Semin. Immunopathol. 38, 87\u201395. https:\/\/doi.org\/10.1007\/s00281-015-0551-z (2016).","journal-title":"Semin. Immunopathol."},{"key":"70280_CR19","doi-asserted-by":"publisher","first-page":"D901","DOI":"10.1093\/nar\/gkm958","volume":"36","author":"DS Wishart","year":"2008","unstructured":"Wishart, D. S. et al. DrugBank: A knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 36, D901-906. https:\/\/doi.org\/10.1093\/nar\/gkm958 (2008).","journal-title":"Nucleic Acids Res."},{"key":"70280_CR20","doi-asserted-by":"publisher","first-page":"D481","DOI":"10.1093\/nar\/gkv1351","volume":"44","author":"A Fabregat","year":"2016","unstructured":"Fabregat, A. et al. The reactome pathway knowledgebase. Nucleic Acids Res. 44, D481-487. https:\/\/doi.org\/10.1093\/nar\/gkv1351 (2016).","journal-title":"Nucleic Acids Res."},{"key":"70280_CR21","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. KEGG: New perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45, D353-d361. https:\/\/doi.org\/10.1093\/nar\/gkw1092 (2017).","journal-title":"Nucleic Acids Res."},{"key":"70280_CR22","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3109\/08916934.2010.541171","volume":"44","author":"A Besliu","year":"2011","unstructured":"Besliu, A. et al. Peripheral blood lymphocytes analysis detects CD100\/SEMA4D alteration in systemic sclerosis patients. Autoimmunity 44, 427\u2013436. https:\/\/doi.org\/10.3109\/08916934.2010.541171 (2011).","journal-title":"Autoimmunity"},{"key":"70280_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrrheum.2011.149","volume":"8","author":"S Bhattacharyya","year":"2011","unstructured":"Bhattacharyya, S., Wei, J. & Varga, J. Understanding fibrosis in systemic sclerosis: Shifting paradigms, emerging opportunities. Nat. Rev. Rheumatol. 8, 42\u201354. https:\/\/doi.org\/10.1038\/nrrheum.2011.149 (2011).","journal-title":"Nat. Rev. Rheumatol."},{"key":"70280_CR24","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/nrrheum.2014.53","volume":"10","author":"YY Ho","year":"2014","unstructured":"Ho, Y. Y., Lagares, D., Tager, A. M. & Kapoor, M. Fibrosis\u2014A lethal component of systemic sclerosis. Nat. Rev. Rheumatol. 10, 390\u2013402. https:\/\/doi.org\/10.1038\/nrrheum.2014.53 (2014).","journal-title":"Nat. Rev. Rheumatol."},{"key":"70280_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/art.40533","author":"Y Yokoyama","year":"2018","unstructured":"Yokoyama, Y. et al. Inhibitory regulation of skin fibrosis in systemic sclerosis by apelin\/APJ signaling. Arthritis. Rheumatol. https:\/\/doi.org\/10.1002\/art.40533 (2018).","journal-title":"Arthritis. Rheumatol."},{"key":"70280_CR26","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1002\/art.27498","volume":"62","author":"A Yoshizaki","year":"2010","unstructured":"Yoshizaki, A. et al. Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis. Arthritis. Rheum. 62, 2476\u20132487. https:\/\/doi.org\/10.1002\/art.27498 (2010).","journal-title":"Arthritis. Rheum."},{"key":"70280_CR27","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1124\/pr.115.011833","volume":"68","author":"AP Davenport","year":"2016","unstructured":"Davenport, A. P. et al. Endothelin. Pharmacol. Rev. 68, 357\u2013418. https:\/\/doi.org\/10.1124\/pr.115.011833 (2016).","journal-title":"Pharmacol. Rev."},{"key":"70280_CR28","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.1210\/en.2010-0754","volume":"151","author":"P Melgar-Lesmes","year":"2010","unstructured":"Melgar-Lesmes, P. et al. Apelin mediates the induction of profibrogenic genes in human hepatic stellate cells. Endocrinology 151, 5306\u20135314. https:\/\/doi.org\/10.1210\/en.2010-0754 (2010).","journal-title":"Endocrinology"},{"key":"70280_CR29","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1159\/000336649","volume":"49","author":"J Ohanian","year":"2012","unstructured":"Ohanian, J., Forman, S. P., Katzenberg, G. & Ohanian, V. Endothelin-1 stimulates small artery VCAM-1 expression through p38MAPK-dependent neutral sphingomyelinase. J. Vasc. Res. 49, 353\u2013362. https:\/\/doi.org\/10.1159\/000336649 (2012).","journal-title":"J. Vasc. Res."},{"key":"70280_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1126\/science.1257601","volume":"347","author":"J Menche","year":"2015","unstructured":"Menche, J. et al. Disease networks. Uncovering disease-disease relationships through the incomplete interactome. Science 347, 125\u20137601. https:\/\/doi.org\/10.1126\/science.1257601 (2015).","journal-title":"Science"},{"key":"70280_CR31","doi-asserted-by":"publisher","first-page":"e1004120","DOI":"10.1371\/journal.pcbi.1004120","volume":"11","author":"SD Ghiassian","year":"2015","unstructured":"Ghiassian, S. D., Menche, J. & Barabasi, A. L. A DIseAse MOdule Detection (DIAMOnD) algorithm derived from a systematic analysis of connectivity patterns of disease proteins in the human interactome. PLoS Comput. Biol. 11, e1004120. https:\/\/doi.org\/10.1371\/journal.pcbi.1004120 (2015).","journal-title":"PLoS Comput. Biol."},{"key":"70280_CR32","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1093\/hmg\/ddv001","volume":"24","author":"A Sharma","year":"2015","unstructured":"Sharma, A. et al. A disease module in the interactome explains disease heterogeneity, drug response and captures novel pathways and genes in asthma. Hum. Mol. Genet. 24, 3005\u20133020. https:\/\/doi.org\/10.1093\/hmg\/ddv001 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"70280_CR33","doi-asserted-by":"publisher","first-page":"e13984","DOI":"10.1371\/journal.pone.0013984","volume":"5","author":"D Merico","year":"2010","unstructured":"Merico, D., Isserlin, R., Stueker, O., Emili, A. & Bader, G. D. Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS ONE 5, e13984. https:\/\/doi.org\/10.1371\/journal.pone.0013984 (2010).","journal-title":"PLoS ONE"},{"key":"70280_CR34","volume-title":"Network Science","author":"AL Barab\u00e1si","year":"2016","unstructured":"Barab\u00e1si, A. L. & P\u00f2sfai, M. \u00c3. Network Science (Cambridge University Press, Cambridge, 2016)."},{"key":"70280_CR35","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/35019019","volume":"406","author":"R Albert","year":"2000","unstructured":"Albert, R., Jeong, H. & Barabasi, A. L. Error and attack tolerance of complex networks. Nature 406, 378\u2013382. https:\/\/doi.org\/10.1038\/35019019 (2000).","journal-title":"Nature"},{"key":"70280_CR36","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13075-015-0721-3","volume":"17","author":"JK Gordon","year":"2015","unstructured":"Gordon, J. K. et al. Nilotinib (Tasigna) in the treatment of early diffuse systemic sclerosis: An open-label, pilot clinical trial. Arthritis. Res. Ther. 17, 213. https:\/\/doi.org\/10.1186\/s13075-015-0721-3 (2015).","journal-title":"Arthritis. Res. Ther."},{"key":"70280_CR37","doi-asserted-by":"publisher","first-page":"e2696","DOI":"10.1371\/journal.pone.0002696","volume":"3","author":"A Milano","year":"2008","unstructured":"Milano, A. et al. Molecular subsets in the gene expression signatures of scleroderma skin. PLoS ONE 3, e2696. https:\/\/doi.org\/10.1371\/journal.pone.0002696 (2008).","journal-title":"PLoS ONE"},{"key":"70280_CR38","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.cell.2011.03.001","volume":"144","author":"D Pe'er","year":"2011","unstructured":"Pe\u2019er, D. & Hacohen, N. Principles and strategies for developing network models in cancer. Cell 144, 864\u2013873. https:\/\/doi.org\/10.1016\/j.cell.2011.03.001 (2011).","journal-title":"Cell"},{"key":"70280_CR39","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.tig.2012.11.004","volume":"29","author":"LI Furlong","year":"2013","unstructured":"Furlong, L. I. Human diseases through the lens of network biology. Trends Genet. 29, 150\u2013159. https:\/\/doi.org\/10.1016\/j.tig.2012.11.004 (2013).","journal-title":"Trends Genet."},{"key":"70280_CR40","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1002\/1529-0131(200010)43:10<2240::Aid-anr11>3.0.Co;2-2","volume":"43","author":"H Ihn","year":"2000","unstructured":"Ihn, H. & Tamaki, K. Increased phosphorylation of transcription factor Sp1 in scleroderma fibroblasts: Association with increased expression of the type I collagen gene. Arthritis. Rheum. 43, 2240\u20132247. https:\/\/doi.org\/10.1002\/1529-0131(200010)43:10<2240::Aid-anr11>3.0.Co;2-2 (2000).","journal-title":"Arthritis. Rheum."},{"key":"70280_CR41","doi-asserted-by":"publisher","first-page":"232ra250","DOI":"10.1126\/scitranslmed.3008264","volume":"6","author":"S Bhattacharyya","year":"2014","unstructured":"Bhattacharyya, S. et al. FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signaling. Sci. Transl. Med. 6, 232ra250. https:\/\/doi.org\/10.1126\/scitranslmed.3008264 (2014).","journal-title":"Sci. Transl. Med."},{"key":"70280_CR42","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal3765","author":"D Lagares","year":"2017","unstructured":"Lagares, D. et al. Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.aal3765 (2017).","journal-title":"Sci. Transl. Med."},{"key":"70280_CR43","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1164\/rccm.201108-1574OC","volume":"185","author":"JF Xu","year":"2012","unstructured":"Xu, J. F. et al. Statins and pulmonary fibrosis: The potential role of NLRP3 inflammasome activation. Am. J. Respir. Crit. Care Med. 185, 547\u2013556. https:\/\/doi.org\/10.1164\/rccm.201108-1574OC (2012).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"70280_CR44","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1378\/chest.08-0943","volume":"134","author":"AB Fernandez","year":"2008","unstructured":"Fernandez, A. B., Karas, R. H., Alsheikh-Ali, A. A. & Thompson, P. D. Statins and interstitial lung disease: A systematic review of the literature and of food and drug administration adverse event reports. Chest 134, 824\u2013830. https:\/\/doi.org\/10.1378\/chest.08-0943 (2008).","journal-title":"Chest"},{"key":"70280_CR45","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1056\/NEJMoa042976","volume":"353","author":"M Demedts","year":"2005","unstructured":"Demedts, M. et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N. Engl. J. Med. 353, 2229\u20132242. https:\/\/doi.org\/10.1056\/NEJMoa042976 (2005).","journal-title":"N. Engl. J. Med."},{"key":"70280_CR46","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1164\/rccm.201506-1063ST","volume":"192","author":"G Raghu","year":"2015","unstructured":"Raghu, G. et al. An Official ATS\/ERS\/JRS\/ALAT clinical practice guideline: Treatment of idiopathic pulmonary fibrosis an update of the 2011 clinical practice guideline. Am. J. Respir. Crit. Care Med. 192, e3\u2013e19. https:\/\/doi.org\/10.1164\/rccm.201506-1063ST (2015).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"70280_CR47","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1164\/rccm.201505-1010OC","volume":"192","author":"JM Oldham","year":"2015","unstructured":"Oldham, J. M. et al. TOLLIP, MUC5B, and the response to N-Acetylcysteine among Individuals with Idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 192, 1475\u20131482. https:\/\/doi.org\/10.1164\/rccm.201505-1010OC (2015).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"70280_CR48","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.drudis.2016.05.015","volume":"21","author":"W Sun","year":"2016","unstructured":"Sun, W., Sanderson, P. E. & Zheng, W. Drug combination therapy increases successful drug repositioning. Drug Discov. Today 21, 1189\u20131195. https:\/\/doi.org\/10.1016\/j.drudis.2016.05.015 (2016).","journal-title":"Drug Discov. Today"},{"key":"70280_CR49","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1136\/annrheumdis-2013-203729","volume":"72","author":"B Maurer","year":"2013","unstructured":"Maurer, B. et al. Levels of target activation predict antifibrotic responses to tyrosine kinase inhibitors. Ann. Rheum. Dis. 72, 2039\u20132046. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203729 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"70280_CR50","doi-asserted-by":"publisher","first-page":"D369","DOI":"10.1093\/nar\/gkw1102","volume":"45","author":"A Chatr-Aryamontri","year":"2017","unstructured":"Chatr-Aryamontri, A. et al. The BioGRID interaction database: 2017 update. Nucleic Acids Res. 45, D369-d379. https:\/\/doi.org\/10.1093\/nar\/gkw1102 (2017).","journal-title":"Nucleic Acids Res."},{"key":"70280_CR51","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1073\/pnas.0610772104","volume":"104","author":"NC Duarte","year":"2007","unstructured":"Duarte, N. C. et al. Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc. Natl. Acad. Sci. USA 104, 1777\u20131782. https:\/\/doi.org\/10.1073\/pnas.0610772104 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70280_CR52","doi-asserted-by":"publisher","first-page":"D261","DOI":"10.1093\/nar\/gkr1122","volume":"40","author":"PV Hornbeck","year":"2012","unstructured":"Hornbeck, P. V. et al. PhosphoSitePlus: A comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res. 40, D261-270. https:\/\/doi.org\/10.1093\/nar\/gkr1122 (2012).","journal-title":"Nucleic Acids Res."},{"key":"70280_CR53","doi-asserted-by":"publisher","first-page":"D841","DOI":"10.1093\/nar\/gkr1088","volume":"40","author":"S Kerrien","year":"2012","unstructured":"Kerrien, S. et al. The IntAct molecular interaction database in 2012. Nucleic Acids Res. 40, D841-846. https:\/\/doi.org\/10.1093\/nar\/gkr1088 (2012).","journal-title":"Nucleic Acids Res."},{"key":"70280_CR54","doi-asserted-by":"publisher","first-page":"D767","DOI":"10.1093\/nar\/gkn892","volume":"37","author":"TS Keshava Prasad","year":"2009","unstructured":"Keshava Prasad, T. S. et al. Human protein reference database\u20142009 update. Nucleic Acids Res. 37, D767\u2013D772. https:\/\/doi.org\/10.1093\/nar\/gkn892 (2009).","journal-title":"Nucleic Acids Res."},{"key":"70280_CR55","doi-asserted-by":"publisher","first-page":"D857","DOI":"10.1093\/nar\/gkr930","volume":"40","author":"L Licata","year":"2012","unstructured":"Licata, L. et al. MINT, the molecular interaction database: 2012 update. Nucleic Acids Res. 40, D857-861. https:\/\/doi.org\/10.1093\/nar\/gkr930 (2012).","journal-title":"Nucleic Acids Res."},{"key":"70280_CR56","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/nar\/gkg108","volume":"31","author":"V Matys","year":"2003","unstructured":"Matys, V. et al. TRANSFAC: Transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 31, 374\u2013378 (2003).","journal-title":"Nucleic Acids Res."},{"key":"70280_CR57","doi-asserted-by":"publisher","first-page":"D497","DOI":"10.1093\/nar\/gkp914","volume":"38","author":"A Ruepp","year":"2010","unstructured":"Ruepp, A. et al. CORUM: The comprehensive resource of mammalian protein complexes\u20142009. Nucleic Acids Res. 38, D497-501. https:\/\/doi.org\/10.1093\/nar\/gkp914 (2010).","journal-title":"Nucleic Acids Res."},{"key":"70280_CR58","doi-asserted-by":"publisher","first-page":"rs8","DOI":"10.1126\/scisignal.2001699","volume":"4","author":"A Vinayagam","year":"2011","unstructured":"Vinayagam, A. et al. A directed protein interaction network for investigating intracellular signal transduction. Sci Signal 4, rs8. https:\/\/doi.org\/10.1126\/scisignal.2001699 (2011).","journal-title":"Sci Signal"},{"key":"70280_CR59","doi-asserted-by":"publisher","first-page":"D362","DOI":"10.1093\/nar\/gkw937","volume":"45","author":"D Szklarczyk","year":"2017","unstructured":"Szklarczyk, D. et al. The STRING database in 2017: Quality-controlled protein\u2013protein association networks, made broadly accessible. Nucleic Acids Res. 45, D362-d368. https:\/\/doi.org\/10.1093\/nar\/gkw937 (2017).","journal-title":"Nucleic Acids Res."},{"key":"70280_CR60","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie, D. A. et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462, 108\u2013112. https:\/\/doi.org\/10.1038\/nature08460 (2009).","journal-title":"Nature"}],"updated-by":[{"DOI":"10.1038\/s41598-021-87277-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T00:00:00Z","timestamp":1617926400000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70280-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70280-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70280-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T15:34:24Z","timestamp":1670340864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70280-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,7]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["70280"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-70280-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,7]]},"assertion":[{"value":"4 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-021-87277-w","URL":"https:\/\/doi.org\/10.1038\/s41598-021-87277-w","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13393"}}